BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35853035)

  • 1. Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.
    Conti B; Bochaton A; Charreire H; Kitzis-Bonsang H; Desprès C; Baffert S; Ngô C
    PLoS One; 2022; 17(7):e0271319. PubMed ID: 35853035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).
    Celaya MO; Berke EM; Onega TL; Gui J; Riddle BL; Cherala SS; Rees JR
    Rural Remote Health; 2010; 10(2):1361. PubMed ID: 20438282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic Access to Mammography and Its Relationship to Breast Cancer Screening and Stage at Diagnosis: A Systematic Review.
    Khan-Gates JA; Ersek JL; Eberth JM; Adams SA; Pruitt SL
    Womens Health Issues; 2015; 25(5):482-93. PubMed ID: 26219677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stage at diagnosis: is travel time important?
    Henry KA; Boscoe FP; Johnson CJ; Goldberg DW; Sherman R; Cockburn M
    J Community Health; 2011 Dec; 36(6):933-42. PubMed ID: 21461957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic access to radiation therapy facilities and disparities of early-stage breast cancer treatment.
    Lin Y; Wimberly MC; Da Rosa P; Hoover J; Athas WF
    Geospat Health; 2018 May; 13(1):622. PubMed ID: 29772881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The joint effects of census tract poverty and geographic access on late-stage breast cancer diagnosis in 10 US States.
    Henry KA; Sherman R; Farber S; Cockburn M; Goldberg DW; Stroup AM
    Health Place; 2013 May; 21():110-21. PubMed ID: 23454732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing GIS-based measures in access to mammography and their validity in predicting neighborhood risk of late-stage breast cancer.
    Lian M; Struthers J; Schootman M
    PLoS One; 2012; 7(8):e43000. PubMed ID: 22952626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography.
    Onega T; Cook A; Kirlin B; Shi X; Alford-Teaster J; Tuzzio L; Buist DS
    Breast Cancer Res Treat; 2011 Aug; 129(1):269-75. PubMed ID: 21553117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-economic and health access determinants of breast and cervical cancer screening in low-income countries: analysis of the World Health Survey.
    Akinyemiju TF
    PLoS One; 2012; 7(11):e48834. PubMed ID: 23155413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic access to breast imaging for US women.
    Onega T; Hubbard R; Hill D; Lee CI; Haas JS; Carlos HA; Alford-Teaster J; Bogart A; DeMartini WB; Kerlikowske K; Virnig BA; Buist DS; Henderson L; Tosteson AN
    J Am Coll Radiol; 2014 Sep; 11(9):874-82. PubMed ID: 24889479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Panagopoulou P; Gogas H; Dessypris N; Maniadakis N; Fountzilas G; Petridou ET
    Eur J Epidemiol; 2012 Nov; 27(11):857-66. PubMed ID: 23086284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A catchment and location-allocation analysis of mammography access in Delaware, US: implications for disparities in geographic access to breast cancer screening.
    Webster JL; Goldstein ND; Rowland JP; Tuite CM; Siegel SD
    Breast Cancer Res; 2023 Nov; 25(1):137. PubMed ID: 37941020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mammography accessibility, deprivation and spatial effect in breast cancer screening participation in France: an observational ecological study.
    Prajapati N; Soler-Michel P; Vieira VM; Padilla CM
    Int J Health Geogr; 2022 Dec; 21(1):21. PubMed ID: 36566241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between individual and geographic factors and nonadherence to mammography screening guidelines.
    Henry KA; McDonald K; Sherman R; Kinney AY; Stroup AM
    J Womens Health (Larchmt); 2014 Aug; 23(8):664-74. PubMed ID: 24865409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does distance matter? Distance to mammography facilities and stage at diagnosis of breast cancer in Kentucky.
    Huang B; Dignan M; Han D; Johnson O
    J Rural Health; 2009; 25(4):366-71. PubMed ID: 19780916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographical and seasonal barriers to mammography services and breast cancer stage at diagnosis.
    Onitilo AA; Liang H; Stankowski RV; Engel JM; Broton M; Doi SA; Miskowiak DA
    Rural Remote Health; 2014; 14(3):2738. PubMed ID: 25018129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic access to mammography screening centre and participation of women in the Quebec Breast Cancer Screening Programme.
    St-Jacques S; Philibert MD; Langlois A; Daigle JM; Pelletier E; Major D; Brisson J
    J Epidemiol Community Health; 2013 Oct; 67(10):861-7. PubMed ID: 23851149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screening among women in metropolitan areas of the United States by county-level commuting time to work and use of public transportation, 2004 and 2006.
    Coughlin SS; King J
    BMC Public Health; 2010 Mar; 10():146. PubMed ID: 20302614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Level Access to Breast Cancer Early Detection and Diagnosis in Nigeria.
    Omisore AD; Sutton EJ; Akinola RA; Towoju AG; Akhigbe A; Ebubedike UR; Tansley G; Olasehinde O; Goyal A; Akinde AO; Alatise OI; Mango VL; Kingham TP; Knapp GC
    JCO Glob Oncol; 2023 Sep; 9():e2300093. PubMed ID: 38096465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.